Refine Search
(1)
(8)
(23)
(71)

Metabolic Disorder

GlobalData provides unique and market-leading data and insights into the metabolic disorder market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Osteoporosis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • March 2019
Add to Basket Quick View Add to Saved List

Osteoporosis is a disease in which the density and quality of bone are reduced over time. In a natural process known as remodeling, some of the bone cells dissolve (resorption) and new bone cells grow back (formation). For people with osteoporo...

Cardiometabolic Disease Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cardiometabolic Disease Global Clinical Trials Review, H2, 2018" provides an overview of Cardiometabolic Disease clinical trials scenario. This report provides top line data relating to the clinical...

Pompe Disease: Opportunity Analysis and Forecasts to 2027

  • $10,995
  • November 2018
Add to Basket Quick View Add to Saved List

Pompe disease (PD) is a rare genetic disorder resulting in the accumulation of glycogen with lysosomes in various tissues of the body. It is caused by a multitude of different phenotypical mutations to the GAA gene which is responsible for the ...

Pompe Disease: Epidemiology Forecast to 2027

  • $3,995
  • November 2018
Add to Basket Quick View Add to Saved List

Pompe disease is a rare multisystem disorder caused by pathogenic variations in the GAA gene, which contains the information for production and function of a protein called acid alpha-glucosidase (GAA). Because of the shortage of this protein (...

Obesity: Competitive Landscape to 2026

  • $3,495
  • October 2018
Add to Basket Quick View Add to Saved List

Obesity is a preventable chronic condition, defined as abnormal or excessive fat accumulation characterized by raised body mass index (BMI ≥30), which is a major risk factor for chronic diseases such as cardiovascular diseases (CVD), diabetes, ...

Abdominal Obesity Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Abdominal Obesity Global Clinical Trials Review, H2, 2018" provides an overview of Abdominal Obesity clinical trials scenario. This report provides top line data relating to the clinical trials on A...

Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018" provides an overview of Diabetic Foot Infection (DFI) clinical trials scenario. This report provides top line data relating to ...

Amyloidosis Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H2, 2018" provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. ...

Type 1 Diabetes: Competitive Landscape to 2026

  • $3,495
  • September 2018
Add to Basket Quick View Add to Saved List

Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells of the pancreatic islet, which means that the body can no longer produce insulin. T1D can develop at any age, but is frequently observed in children and adolesc...

Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2018

  • $2,500
  • September 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Tumor Lysis Syndrome clinical trials scenario. This report provides top line data relating to the clinical trial...

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018

  • $2,500
  • September 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018" provides an overview of Type 1 Diabetes (Juvenile Diabetes) clinical trials scenario. This report provides top line data ...

Digital Landscape: Type 2 Diabetes

  • $6,000
  • August 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Type 2 Diabetes report analyzes digital activities undertaken by Pharma in support of therapies for Type 2 Diabetes (T2D).

Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018" provides an overview of Primary Systemic Amyloidosis clinical trials scenario. This report provides top line data relating to th...

Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2018" provides an overview of Proliferative Diabetic Retinopathy (PDR) clinical trials scenario. This report provides top ...

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2018" provides an overview of Phenylketonuria (PKU) clinical trials scenario. This report provides top line data relating to the clinical tri...

Join our mailing list
Find out first about the latest reports and offers.